Clinical Trials
2
Active:0
Completed:2
Trial Phases
2 Phases
Phase 1:1
Phase 2:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials
Phase 1
1 (50.0%)Phase 2
1 (50.0%)Safety, Efficacy, and Tolerability Study of ASP3291 in Patients With Active Ulcerative Colitis
- First Posted Date
- 2012-06-05
- Last Posted Date
- 2016-09-28
- Lead Sponsor
- Telsar Pharma Inc.
- Target Recruit Count
- 112
- Registration Number
- NCT01612039
A Study of a Single Dose of ASP3291 in Subjects With Ulcerative Colitis
- First Posted Date
- 2011-03-22
- Last Posted Date
- 2012-07-24
- Lead Sponsor
- Telsar Pharma Inc.
- Target Recruit Count
- 16
- Registration Number
- NCT01320332
- Locations
- 🇺🇸
Advanced Clinical Research Institute, Anaheim, California, United States
🇺🇸SNBL Clinical Pharmacology Center, Baltimore, Maryland, United States
🇺🇸Clinical Trials of Texas, Inc., San Antonio, Texas, United States
News
No news found